Hsin, Taiwan

Lain-tze Lee

This inventor holds 1 USPTO granted patent and 5 published patent applications and 2 EPO patents. Top assignee: Industrial Technology Research Institute. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lain-tze Lee. Retrieved from https://idiyas.com/inventor/lain-tze-lee-sajfz3pn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lain-tze Lee: Innovator in Hepatitis B Treatment

Introduction

Lain-tze Lee is an inventor based in Hsinchu, Taiwan. He is associated with the Industrial Technology Research Institute, where he focuses on innovative solutions in the field of medicine. Although he currently holds no granted patents, his work is significant in the realm of hepatitis treatment.

Latest Patent Applications

Lain-tze Lee has submitted several notable patent applications. One of his latest applications is titled "Method for Treating Hepatitis B." This disclosure provides a method for treating hepatitis B, including administering an effective amount of proanthocyanidins. The formula of a monomer of the proanthocyanidins is shown as Formula (I). Another application is "Boehmeria Extract and Its Use in Treating Liver Diseases." This pharmaceutical composition is prepared from a specific species and can be used to improve liver function, treat liver disease, and promote liver tissue regeneration.

Conclusion

Lain-tze Lee's contributions to the field of hepatitis treatment through his innovative patent applications highlight his commitment to advancing medical science. His work has the potential to make a significant impact on liver health and disease management.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…